Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Genentech reports earnings

DNA posted net income of $246.7 million ($0.93) last year, a 36 percent

Read the full 133 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE